The annual Haematology Summit took place in Dublin on September 6, 2024, attracting healthcare professionals involved in the care of patients with haematological malignancies. Discussions focused on the latest insights into the diagnosis and treatment of diseases such as multiple myeloma, chronic lymphocytic leukaemia (CLL), and acute myeloid leukaemia (AML). Key speakers emphasized the importance of personalized treatment strategies, including the use of new therapies like CAR-T cells and bispecific antibodies for multiple myeloma. The event also featured discussions on the genetics revolution in AML and strategies for managing haematological malignancies to improve patient outcomes and quality of life.
Source link
New horizons in blood cancer – shared perspectives on management of Multiple Myeloma, CLL, and AML
